The work

Research notes, strategy write-ups, and the code behind them.

Everything here is written to the same standard: state the hypothesis, define the rule, price the risk, and show what would prove it wrong. Figures labeled illustrative are reconstructed to explain methodology — they are not live track records.

16 items / all work
01 ForgeAlpha An autonomous multi-agent research platform: idea to validated, documented, paper-traded strategy — with every number produced by deterministic software, not a model. System design 2026 02 Regime-aware risk allocation Sizing by measured regime and a volatility budget, with a de-grossing ladder that acts before the drawdown. Strategy 2026 03 Short-dated options, defined risk A variance-premium process for 0–5 DTE index and large-cap options, sized by maximum loss. Strategy 2026 04 How I underwrite a business A repeatable process for equity research: quality, normalized earnings, embedded expectations, disconfirmation. Equity research 2026 05 Engineered scorecards Turning discretionary observations into a weighted, auditable composite signal that can be tested. Concept 2026 06 Building in QuantConnect Porting the research into LEAN: point-in-time data, survivorship, fill modeling, parameter stability. Build log 2026 07 Time-series momentum, four asset classes Sixteen ETFs, monthly, 7% volatility budget. 6.53% CAGR and 0.821 Sharpe over 2001–2026 against SPY’s 9.02% and 0.550, with a 14.3% drawdown. Walk-forward Sharpe 0.736. Strategy 2026 08 Volatility-managed equity exposure The S&P 500 held at a constant 8% risk budget instead of a constant weight. 0.829 Sharpe and a 22.6% drawdown against 0.550 and 55.2% for buy-and-hold. Strategy 2026 09 Breakout trend with a barrier stop 100-day Donchian entries, 30-day exits, plus a volatility-scaled stop. Alpha of 7.30% a year against the S&P 500 with a 0.04 beta; 9.32% CAGR in the 2016–2026 holdout. Strategy 2026 10 Cross-sectional momentum in sectors Twelve-minus-one momentum across nine US sectors and seven country/real-asset ETFs, top five, inverse-volatility weighted. 7.64% CAGR; 2008 is the honest failure case. Strategy 2026 11 The triple barrier, tested Meta-labelling, barrier exits and barrier stops applied to four books. The classifier has no out-of-sample skill (AUC 0.51); the stop leg is the only part that earns its keep. A negative result, documented. Research 2026 12 Micron Technology — HOLD, $940 The most profitable year in memory history at 6.6× sales, with a forward P/E of 3.9× that assumes the cycle does not turn. We are not sellers; we are not adding either. Equity research 2026 13 UnitedHealth — BUY, $470 Operating margin fell from 8.1% to 4.2% in one year. A return to a mid-6% margin on $460B of revenue is worth $23 of EPS; at 20× that is $470. Equity research 2026 14 Nike — SELL, $33 Three years of turnaround without a margin. Revenue is flat, free cash flow has fallen 67%, and the 4.3% dividend is not covered by it. Equity research 2026 15 ExxonMobil — HOLD, $175 The best cash-return story in integrated oil, priced like it after a 43% year. A 3.5% free-cash-flow yield and a 2.6% dividend; we would buy at $145–150. Equity research 2026 16 Academic archive Fourteen college work samples — equity research, stock pitches, industry studies and group presentations from the University of Alabama, 2021–2025. Academic 2025
On performance figures

Charts and tables on these pages are illustrative reconstructions used to explain a method — the shape of a drawdown, the geometry of a payoff, the sensitivity of a valuation. They are not audited results and should not be read as a track record. Live research, full backtests and code are available on request.